diallyl trisulfide has been researched along with hes1 protein, human in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Li, Y; Si, M; Yin, H; Zhang, J; Zhang, L | 1 |
1 other study(ies) available for diallyl trisulfide and hes1 protein, human
| Article | Year |
|---|---|
Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling.
Topics: Allyl Compounds; Antineoplastic Agents; Basic Helix-Loop-Helix Transcription Factors; Cell Movement; Cell Proliferation; Cell Survival; Collagen; Culture Media, Conditioned; Drug Combinations; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Human Umbilical Vein Endothelial Cells; Humans; Laminin; Matrix Metalloproteinase 2; MicroRNAs; Neoplasm Invasiveness; Neovascularization, Pathologic; Osteosarcoma; Proteoglycans; Receptor, Notch1; RNA, Small Interfering; Signal Transduction; Sulfides; Transcription Factor HES-1; Transfection; Vascular Endothelial Growth Factor A | 2013 |